- Retraction Note
- Open access
- Published:
Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 174 (2023)
Retraction Note: J Exp Clin Cancer Res 37, 52 (2018)
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding highly similar images in the present figures, specifically:
-
The Transwell assay images in Fig. 6e and f, and 7i appear to contain multiple overlapping panels;
-
A number of images in Fig. 6e appear highly similar to those in Figs. 4d and 5d in the authors’ earlier article [1].
-
Figure 7h middle panel p-Akt lanes 3 and 4 appear highly similar to Fig. 7k right panel N-Cad lanes 1 and 2.
-
Figure 7h left and right panel b-actin blots appear highly similar to those in Fig. 7k, but the middle panel blots are different.
Additionally, the study used Bel7402 and Bel/5-FU cell lines, which have both been reported to be HeLa derivatives. Therefore, these cells are not suitable models for hepatocellular carcinoma.
The authors have provided the raw data from the Transwell, immunohistochemistry and western blot assays. However, further checks by the publisher found labelling errors in the original western blot data that may have affected the results and conclusions of the article. The Editor-in-Chief therefore no longer has confidence in the presented data.
Corresponding Author Tao Tian has stated on behalf of all co-authors that they do not agree to this retraction.
References
Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, et al. Micro RNA-155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI 3K/Akt pathway. Cancer Sci. 2017;108(4):620–31. https://doi.org/10.1111/cas.13177.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-018-0677-7.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Fu, X., Liu, M., Qu, S. et al. Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. J Exp Clin Cancer Res 42, 174 (2023). https://doi.org/10.1186/s13046-023-02761-7
Published:
DOI: https://doi.org/10.1186/s13046-023-02761-7